Episode 90
š§¬ Neela Patel - Bonum Therapeutics - Part 3 | Developing Pipeline Strategy at Poniard Pharmaceuticals | Business & Corporate Development in Oncology | Transitioning from Abbott to AbbVie to Seagen
Part 3 of 4: Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development. Before her time at Bonum Therapeutics Neela worked as the CBO at Good Therapeutics, a biotech company that develops cutting edge protein-based drugs. Her impressive career also includes pivotal roles at Seattle Genetics, AbbVie, Abbott, and Genentech. Her extensive experience as both a scientist and business person give her unique insights you wonāt want to miss.
The Biotech Startups Podcast Ā· Excedr
October 28, 202440m 6s
Audio is streamed directly from the publisher (media.fame.so) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Part 3 of 4:
Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development.
Before her time at Bonum Therapeutics Neela worked as the CBO at Good Therapeutics, a biotech company that develops cutting edge protein-based drugs. Her impressive career also includes pivotal roles at Seattle Genetics, AbbVie, Abbott, and Genentech. Her extensive experience as both a scientist and business person give her unique insights you wonāt want to miss.
Join us this week to hear about:
- Neelaās transition from Genentech to Poniard Pharmaceuticals
- Her collaboration with Greg Hageman on age-related macular degeneration
- Raising $37 million in Series A financing
- Neelaās role at Poniard developing pipeline strategy with the head of chemistry
- Her experiences at Abbott and AbbVie as Director of Global External Research and Search & Evaluation, respectively.
Please enjoy Jonās conversation with Neela Patel!
Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Find Our Guest, Neela Patel, at these links:
Find Our Host, Jon Chee, at these links:
Excedr Socials & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Genentech: https://www.gene.com/
Poniard Pharmaceuticals: https://www.linkedin.com/company/poniard-pharmaceuticals/
Abbott: https://www.abbott.com/
AbbVie: https://www.abbvie.com/
Seattle Genetics (Pfizer): https://www.seagen.com/who-we-are/history
Patents Licensing in Biotech: https://www.excedr.com/resources/how-patent-licensing-works
IP Strategy for Biotechs: https://www.excedr.com/resources/intellectual-property-strategy-for-biotechs
Partnering with Big Pharma: https://www.excedr.com/blog/how-biotech-partnerships-support-research
Antibody Drug Conjugates (Prime Antibody): https://www.excedr.com/resources/primary-antibody
Corporate Development: https://corporatefinanceinstitute.com/resources/management/corporate-development-guide/
In Licensing and Out Licensing: https://www.excedr.com/blog/life-sciences-licensing-agreements-guide
Bootstrapping Your Biotech: https://www.excedr.com/resources/how-to-bootstrap-biotech-startup
People Mentioned:
Greg Hageman: https://medicine.utah.edu/faculty/gregory-s-hageman
Steve Dedinson: https://www.linkedin.com/in/steve-davidsen-0a65414/
Saul Rosenberg: https://www.linkedin.com/in/saul-rosenberg-638a6910/
Timestamps:
00:28 Intro
01:50 Starting a company after Genentech experience
02:36 Greg Hagemanās key gene discovery and securing Series A funding
05:32 Developing pipeline strategy at Poniard
06:43 Transitioning to BD (Search and Evaluation) at Abbott
12:31 Spinning out AbbVie, Neelaās continued focus on Oncology
14:58 Fostering innovation and external ideas at AbbVie
16:51 Evaluating small companies & the biggest challenge of Search and Evaluation
20:13 Key factors for startups looking to partner with big pharma
26:32 Transitioning to Seattle Genetics (Seagen) and Corporate Development
29:28 Neelaās CorpDev experience, navigating unique challenges
34:03 Understanding how to diversify revenue streams and navigate cycles
39:01 Outro
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science companyāfrom pre-seed to IPO.